Background: Genetic abnormalities in the Fas receptor or its trimeric ligand, FasL, result in massive T-cell proliferation and a lupus-like autoimmune syndrome, which was initially attributed to excessive lymphoproliferation but is now ascribed to the absence of Fas-mediated cell death. Although Fas is normally expressed on most thymocytes, negative selection seems to be unperturbed in Fasdeficient (lpr) mice. This suggests that Fas has an important function in peripheral, but not thymic, T cells.
Background
The formation and homeostasis of tissues is regulated by the two opposing processes of proliferation and programmed cell death. This is particularly evident in the developing immune system, in which thymocytes capable of reacting with foreign antigens must be selected from a large reservoir of cells with distinct reactivities, while potentially autoreactive or hyporeactive thymocytes must be eliminated. Similarly, in peripheral lymphoid tissue, previously activated, but ultimately obsolete, lymphocytes must be expeditiously removed from the circulation to provide space for T cells with new specificities.
A requisite role for cell-surface receptors in regulating programmed cell death or activation-induced cell death in T cells was established, in part, by the identification of the cell-surface receptor Fas (also called APO-1) in screens for cytolysis-inducing monoclonal antibodies [1] [2] [3] . Fas crosslinking usually leads to a form of programmed cell death, termed apoptosis, which is characterized by condensation of the cell, membrane blebbing, segmentation of the nucleus and internucleosomal DNA degradation [4] . Fas is a member of a growing family of receptors which are similar in their 'cysteine-rich' extracellular domains; these include NGFR (the low-affinity receptor for nerve growth factor), TNFRI and TNFRII (the type I and type II receptors for tumour necrosis factor), CD40, OX40, CD30 and CD27 (reviewed in [5] ). The intracellular 'signaling' domain of Fas, however, only shares homology with a subset of these receptors, including TNFRI, NGFR and a growing subset of TNFRI-and Fas-associated proteins (FAPs) (reviewed in [6] ). In each case, the cytoplasmic homology maps to a conserved 'death domain' which has been shown to be necessary for the cytolytic character of each receptor or signaling molecule [6] [7] [8] . The nickname 'death domain', however, appears to be a misnomer, and rather than providing cytolytic functions it may actually serve as a protein-protein interaction motif for recruiting FAPs. The molecular mechanism(s) by which FAPs couple to downstream signaling cascades has not yet been determined. Naturally occurring Fas mutations provided initial insights into the role of Fas-mediated apoptosis in development [9, 10] . Although Fas is normally expressed in a variety of tissues -including the thymus, liver, lungs and ovariesand in activated B and T cells [1, 3] , mutations in Fas (lpr and lpr cg [11, 12] ) cause phenotypic changes only in hematopoietic cells. (Genetic ablation of Fas also leads to substantial liver hyperplasia [13] .) It has been found that lpr/lpr mice exhibit a pronounced lymphadenophathy with excessive numbers of unusual CD4 -CD8 -(doublenegative) B220 + T cells. These mice also have an autoimmune disorder that is related to systemic lupus erythematosus and is characterized by increased levels of T-cell dependent autoantibodies (reviewed in [9] ). These observations led to the model that the normal function of Fas is in the deletion of autoreactive T and B cells [14] .
Analysis of Fas expression and signaling during a normal immune response suggested an even broader role for Fas. The Fas protein is induced in resting, peripheral T cells within 24 hours after antigen stimulation in vitro, although susceptibility to Fas-mediated death takes several days [15, 16] . This transition correlates with expression of the Fas ligand, FasL, which has been shown to be necessary for activation-induced cell death (reviewed in [17] ). Thus, the antigen receptor controls the expression of Fas and its ligand, and their coexpression leads to cell death. However, during the 'latency' period, crosslinking of surface-bound Fas with anti-Fas monoclonal antibodies or with FasL does not trigger apoptosis, implying that some developmentally regulated restriction to Fas signaling also exists.
Whether Fas signaling is required during thymocyte ontogeny remains unclear. Fas is expressed [18] and functional [19] in the majority of immature CD4 + CD8 + (double-positive) thymocytes, concomitant with thymic selection. Deletion of potentially autoreactive thymocytes, however, seems to proceed normally in lpr mice (which are deficient in Fas) and in gld mice (which are deficient in FasL), indicating that Fas is probably not essential for normal thymic development (reviewed in [9] ). Furthermore, FasL does not seem to be expressed at significant levels in the thymus [20] . Nevertheless, because early thymectomy (less than 2 weeks postpartum) alleviates the lpr defect [21] , a mitigating role for thymus-derived cells in the disease process must exist. The work of Mountz and colleagues [22] offers one resolution by suggesting that although positive and negative selection may proceed normally in lpr mice, otherwise 'neglected' TCR lo thymocytes are the true thymic targets of Fas signaling and may be the precursors of the peripherally expanded T cells.
In order to clarify the role of Fas during thymic development, and to further elucidate the molecular details of Fas signaling, we have developed a means of artificially activating Fas receptor functions by bypassing its natural ligand through the use of a cell-permeable synthetic ligand called FK1012 [23] . Although FasL is apparently trimeric in solution [24] and anti-APO-1 F(ab′) 2 fragments are incapable of triggering apoptosis in vitro [25] , we find that the simple dimerization of two Fas domains can trigger apoptosis. Finally, because FK1012 permeates cells, we were able to study the ability of the conditional Fas receptor to trigger apoptosis in transgenic mice. These studies revealed that double-positive thymocytes are particularly sensitive to Fas-mediated apoptosis. This system should ultimately permit analysis of the role of Fas in a temporally controlled fashion in various tissues, and help to elucidate its role in the B-and T-cell abnormalities of the Fas-deficient mice and in autoimmunity.
Results

FK1012 induces death in lymphocytes expressing the Fas-FKBP fusion protein
To determine the function of Fas during thymic development and to explore signaling mechanisms we used FK1012 to artificially activate Fas [23] . We constructed plasmids that encoded chimeric proteins which contained the cytoplasmic domain of Fas adjacent to one or more tandem copies of the FK1012-binding protein (FKBP), the myristoylation-targeting peptide (M) from the amino terminus of v-src, and the influenza hemagglutinin (HA) epitope (E) (Fig. 1a,b) . The encoded proteins were designated M-Fas-FKBP n -E.
To determine the signaling capacity of M-Fas-FKBP n -E, an expression vector, pM/Fas/FKBP 3 /E-neo, containing the neomycin resistance gene, was electroporated into D10.11 T cells. Initially, G418-resistant clones were selected and screened for responsiveness to 500 nM FK1012. In two clones, D10#10 and D10#20, 100 % of the cells died after incubation with FK1012. Both clones expressed the chimeric construct, as determined by western-blot analysis (data not shown).
To determine whether death was due to necrosis or apoptosis, clone D10#10 was treated for several hours with 250 nM FK1012 and compared with the identically treated parental line (Fig. 1c,d ). Although both lines were initially 95-100 % viable, within 4 hours, pyknotic nuclei and membrane disintegration were prevalent in clone D10#10, whereas the parental line looked normal. Even within 1 hour, pyknotic nuclei and membrane blebbing were detectable in clone D10#10 (data not shown). The LC 50 for death by FK1012 in D10#10 cells was ~15 nM; in contrast, the monomeric FK506-derivative, FK506-M [23] , was inert at concentrations up to 1 M, indicating that crosslinking was required for programmed cell death (data not shown). Internucleosomal chromosomal degradation also appeared promptly after FK1012 treatment in clones D10#10 and D10#20, but was not visible in the parent line (Fig. 1e) . Even after several days of treatment, 250 nM FK1012 had no effect on the viability of the parent D10.11 or on other cell lines (data not shown). Thus, FK1012-mediated intracellular crosslinking of the membrane-tethered cytoplasmic domain of Fas results in apoptosis in T cells, providing a useful tool to dissect Fas-mediated signaling.
Fas dimerization is sufficient for signaling in Jurkat T cells
Although structural features of soluble trimeric FasL suggest that signaling by the Fas receptor might occur by homotrimerization [24] , experimental evidence that multimerization is essential is based solely on crosslinking with antibodies [25, 26] . The approach based on the use of the chemical inducer of dimerization permitted a reanalysis of this question, and allowed the extent of crosslinking to be controlled by the number of FKBP dimerization domains attached to Fas. For these experiments, Fas-mediated apoptosis of transiently transfected cells was assayed by flourescence-activated cell sorting (FACS) analysis (Fig. 2) .
To study the requirements for Fas signaling, plasmids encoding various Fas-FKBP fusion proteins containing 1-3 copies of FKBP12 were transiently transfected into Jurkat-TAg T cells along with a plasmid expressing a truncated signaling-deficient CD8␣ surface marker. After 24 hours, CD8␣ bright cells (2-2.5 % of total) were sorted by FACS and divided into two aliquots. One aliquot was mock-treated ( . Surprisingly, even when only a single FKBP was fused to the Fas signaling domain, a significant degree of apoptosis was still observed (Fig. 2g) . Western blotting of extracts from unsorted, transiently transfected cells demonstrated that the attachment of Fas to the membrane was slightly cytotoxic and consistently led to a 2-3 fold decrease in protein expression. Therefore, the non-myristoylated fusion proteins, ⌬M-FKBP 1 -Fas and ⌬M-FKBP 3 -Fas and M-Fas-cg-FKBP 3 , were consistently expressed at higher levels. However, variation of the number of copies of FKBP had little, if any, effect on the expression of myristoylated M-FKBP n -Fas (data not shown). Therefore, FK1012-mediated crosslinking of Fas is sufficient to induce apoptosis.
Membrane tethering of Fas is essential for triggering apoptosis
A number of cytoplasmic proteins containing death domains have recently been identified [6] . Although their roles in apoptosis are still undefined, the formal possibility exists that the membrane-independent aggregation of one or more of these proteins is sufficient to trigger apoptosis. Because FK1012 is cell-permeable, we were able to investigate whether signaling by a death domain-containing protein requires its association with the membrane. Mutation of the amino-terminal glycine residue of the chimeric Fas constructs disrupts myristoylation, thereby preventing membrane binding [27, 28] . In contrast to the results with membrane-tethered Fas, FK1012 did not trigger apoptosis in cells expressing the non-myristoylated ⌬M-FKBP 3 -Fas protein (compare Fig. 2e ,f with 2c,d); the concentrations of FK1012 used were well in excess of the LC 50 for cells expressing myristoylated Fas. Similar results were achieved when the incubation period with FK1012 was extended to 24 hours (data not shown).
To ensure that proteins not associated with the membrane were expressed efficiently, Fas-FKBP expression in transiently-transfected Jurkat cells was analyzed by western blotting and by confocal microscopy using the anti-HA antibody, 12CA5. Although myristoylated M-FKBP 1 -Fas was primarily localized at the plasma membrane and apparently excluded from the nucleus (Fig. 2h) , nonmyristoylated ⌬M-FKBP 1 -Fas was distributed throughout the cell, including the nucleus (Fig. 2i ). This demonstrated that although comparable amounts of ⌬M-FKBP 1 -Fas were expressed, as determined by confocal microscopy ( Fig. 2h,i ) and western blotting (data not shown), membrane attachment of Fas was required to trigger apoptosis.
Fas signaling leads to the ablation of CD4 + CD8 + thymocytes
To test the ability of a Fas-FKBP fusion protein to trigger apoptosis in primary thymocytes, we produced transgenic mice expressing M-FKBP 2 -Fas under the influence of the Lck proximal promoter [29] . We chose to study a representative mouse line (#8), which expressed easily detectable levels of the transgene product. The ability of FK1012 to induce apoptosis in vitro was compared to that of the corticosteroid dexamethasone, by using FACS analysis based on propidium iodide exclusion. Although dexamethasone elicited apoptosis in the majority (~80 %) of thymocytes from both wild-type and transgenic mice after a 20 hour incubation, FK1012 triggered ~75 % apoptosis only in transgenic thymocytes (data not shown). To determine whether Fas-mediated signaling was developmentally restricted, overnight thymocyte cultures, incubated with dilutions of FK1012, were stained and analyzed for CD4 and CD8 expression, and for viability (Fig. 3) . Only double-positive thymocytes were sensitive to FK1012-mediated cell ablation (Fig. 3d) . Mature singlepositive CD4 -CD8 + and CD4 + CD8 -thymocytes (Fig.  3b ,c, respectively) and immature double-negative thymocytes (Fig. 3a) did not seem to be responsive to Fas signaling. To rule out the formal possibility that only double-positive thymocytes expressed the transgene, single-positive CD4 + CD8 -thymocytes were sorted by FACS and analyzed for transgene expression by western blotting (data not shown). Because expression of the transgene was easily detectable in the CD4 + CD8 -thymocytes (albeit ~4-fold lower than double-positive expression), the greatly reduced ability of Fas to signal apoptosis in singlepositive (CD4 + ) thymocytes cannot be explained simply by a lack of transgene expression. Therefore, the signaling pathway propagating Fas-mediated apoptosis seems to be developmentally restricted. However, these experiments do not rule out that very high levels of Fas signaling could overcome the resistance of single-positive thymocytes to Fas-mediated apoptosis.
FK1012 can efficiently trigger Fas-mediated apoptosis in vivo
Finally, we assessed the ability of FK1012 to trigger apoptosis in thymocytes in vivo by intravenous injection of FK1012 (Fig. 4) . One dose (~20 mg kg -1 ) of FK1012 was administered to wild-type or transgenic mice (Fig. 4a,c , respectively). Alternatively, carrier alone was injected into control mice (Fig. 4b) . The thymocyte subsets were analyzed ~16 hours later. Double-positive thymocytes were almost completely eliminated (mean: ~83 % reduced) in the treated transgenic mice relative to the mock-treated transgenic mice (compare Fig. 4c with 4b) ; this result was similar to that obtained in vitro. Concomitantly, there was a commensurate increase in the proportion of other thymocyte subsets. In contrast, there was a normal distribution of subsets in the FK1012-treated, wild-type mice (Fig. 4a) . Repeated exposure to FK1012 had no detectable effect on wild-type mice (data not shown). Although FK1012 did not eliminate 100 % of double-positive thymocytes in vivo, the normal influx and efflux of cells from the thymus probably reduces the detectability of changes in double-positive cells obtained with only one administration of FK1012, which has a relatively short half life in plasma (less than 1 hour; data not shown). These experiments demonstrate,
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Figure 3
The effects of FK1012 on thymocyte subsets in transgenic mice expressing M-FKBP 2 
Discussion
Dimerization is sufficient for Fas signaling
A variety of observations led to the expectation that dimerization of Fas would be insufficient for signaling. Direct biochemical data [24] and structural comparisons of FasL with the highly homologous tumor necrosis factor ␣ (TNF␣) [20] suggest that FasL is trimeric in solution. TNF␣ is a homotrimer [30, 31] and binds to TNFRI at a ratio of 3:3 [32] . Furthermore, monoclonal antibodies that trigger Fas-mediated cytolysis are either aggregates in solution (CH-11 is an IgM, APO-1 is from the self-associating IgG 3 class) or must be surface-bound [25, 26] . Surprisingly, however, we find that FK1012-mediated dimerization of the death domain of Fas is sufficient for killing, albeit with diminished potency relative to multimerization.
The sufficiency of dimerization is unlikely to be a general artifact of this system because, as we have previously shown, only two FKBPs can bind to one FK1012 molecule.
Furthermore, other signaling receptors, such as the chain of the T-cell receptor complex, clearly require multimerization for signaling using the approach based on chemically induced dimerization [23] . Therefore, although multimerization of the Fas receptor is the most efficient pathway towards programmed cell death, dimerization of the death domain is also capable of triggering apoptosis.
One potential reconciliation of these disparate results is that dimerization mediated by intracellular dimerizing agents can lead to, or augment, intermolecular aggregation of Fas receptors, leading to higher-order multimerization than occurs with anti-Fas monoclonal antibody or FasL. This possibility is consistent with recent reports that the Fas and TNFRI death domains can self-aggregate in vivo if highly overexpressed, leading to auto-signaling and death ( [33] [34] [35] and our unpublished observations). If, however, aggregation occurs normally, it must be via a weak interaction because anti-APO-1 F(ab′) 2 fragments need to be further crosslinked to trigger apoptosis [25] . Additionally, we saw no evidence that the cytosolic Fas fusion protein, ⌬M-FKBP 1 -Fas, interacted with endogenous membrane-bound Fas when the intracellular localization of ectopically expressed Fas was analyzed by confocal microscopy (Fig. 2i) . Although the possibility that a small number of undetected intracellular aggregates can trigger apoptosis cannot be excluded, these experiments demonstrate that the ligand that triggers Fas-mediated apoptosis need not be a multimer. This insight may have an important impact on the design of Fas agonists and/or antagonists.
Membrane attachment is required for Fas-mediated apoptosis in Jurkat cells
The use of intracellular dimerizing agents led to the finding that cytosolic dimerization of Fas is insufficient to signal apoptosis in Jurkat cells, suggesting that Fas probably functions as a scaffold for tethering FAPs to the plasmid membrane. Additionally, this implies that the substrates for FAPs are also membrane-localized. This hypothesis seems at odds with published reports that merely overexpressing the intracellular domain of Fas can be cytotoxic [34] . Although we saw a similar effect using the membrane-tethered intracellular domain, M-Fas, or using M-FKBP n -Fas, this cytotoxic effect was greatly reduced, or absent, when the membrane attachment sequence was removed (data not shown). It will be interesting to see whether direct recruitment to the plasma membrane and dimerization or oligomerization of other molecules that contain death domains -such as FADD, TRADD and RIP [6] -can bypass the need for Fas altogether.
Double-positive thymocytes are selectively Fas-sensitive
Although the Lck proximal promoter is active, and chimeric Fas-FKBP is expressed throughout thymocyte ontogeny, we found that only double-positive thymocytes were sensitive to Fas-mediated killing in vitro. In homozygous transgenic mice, a reduction of single-positive thymocytes was seen only at the highest dose of FK1012 (1 M), arguing that very high levels of Fas crosslinking can partially overcome the refractory nature of single-positive thymocytes to Fas-mediated apoptosis (data not shown). This is consistent with recent reports that singlepositive thymocytes express Fas; nevertheless, these cells are still recalcitrant to Fas-mediated apoptosis ( [19] and our unpublished studies). Therefore, Fas expression is not sufficient for Fas-mediated apoptosis in all cells.
FK1012 leads to apoptosis and rapid elimination of Fas-FKBP-expressing thymocytes in vivo
A single intravenous injection of FK1012 led to the selective elimination of double-positive thymocytes in mice expressing M-Fas-FKBP 2 under the influence of the Lck proximal promoter. Although another report had previously shown the preferential elimination of doublepositive thymocytes after injection of an anti-Fas monoclonal antibody, this treatment led to a profound fulminant hepatitis-like syndrome, and it could not be ruled out that endogenous steroids or other stress-induced serum factors were affecting thymocyte morbidity [19] . We found that the percentage of double-positive cells decreased significantly (mean:~83 % depletion), whereas the proportional representation of the other major populations (that is, double-positive and single-positive cells) experienced a commensurate increase. Interestingly, we only saw a small increase (from ~3 % to ~20 %) in the number of apoptotic cells in the thymus, as assayed by propidium iodide uptake. The prompt disappearance of apoptotic cells has been widely observed and probably reflects the fact that most apoptotic cells are quickly engulfed by phagocytic cells [36] .
A role for Fas in thymic selection?
Whether or not Fas is involved in thymic selection remains controversial. Clearly, Fas is not necessary for the programmed cell death of the majority of double-positive thymocytes, because negative selection and the size of the thymus seem relatively normal in Fas-deficient mice [13] .
If the role of Fas in thymocyte development can be substituted by one or more other proteins, such as the Fas family member CD30, which is essential for at least some negative selection [37] , then an effect of Fas deficiency might not be revealed without creating mice carrying multiple deficiencies.
Conclusions
We have undertaken a novel approach to the study of protein function by treating cells or transgenic animals expressing rationally designed conditional alleles with low molecular weight, synthetic molecules capable of inducing dimerization. The current study investigated the mechanisms of signaling mediated by the Fas receptor. With these synthetic ligands we were able to trigger Fasmediated apoptosis efficiently at an LC 50 as low as 10 nM in vitro, and we ablated a T-cell lineage at a transient concentration of 20 mg kg -1 in vivo.
Surprisingly, we find that the simple dimerization of two Fas domains can trigger apoptosis. Because these reagents permeate cells, we were able to study the role of membrane attachment in Fas signaling, revealing that membrane attachment is necessary for Fas-mediated apoptosis.
We were also able to study the ability of a conditional Fas receptor to trigger apoptosis in transgenic mice. These studies revealed that double-positive thymocytes are particularly sensitive to Fas-mediated apoptosis. This system should ultimately allow us to study the role of Fas in a temporally controlled fashion in various tissues, including its role in the B-and T-cell abnormalities of the Fas-deficient mice and in autoimmunity. This technique potentially allows for any dimerization-initiated signal to be controlled in a tissue-specific fashion, and hence may become a useful tool for the elucidation of signaling events in developmental biology.
Materials and methods
Cell culture
The murine T-cell line D10.11 [38] was grown in complete media (RPMI 1040, 10 % fetal calf serum, 10 mM Hepes buffer (pH 7.4), 50 M ␤-mercaptoethanol, penicillin (100 U ml -1 ), and streptomycin (100 g ml -1 ) containing 10-20 U ml -1 interleukin 2 (IL-2). Every 30 days the cells were restimulated with 10-20 × 10 6 irradiated spleen cells from a C57BL/6 (I-A b ) mouse per 10 6 D10.11 cells. Jurkat-TAg T cells [39] were grown in complete media without IL-2 and ␤-mercaptoethanol.
Construction of chimeric receptors
The nucleotide sequence of the cytoplasmic domain of Fas was amplified by the polymerase chain reaction (PCR) from a Jurkat cDNA library using 5′ primer 11610, 5′-cgacactcgag gta cag aaa aca tgc aga aag c-3′, and 3′ primer 11611, 5′-cgtagagtcgac gac caa gct ttg gat ttc att tc-3′. The primers contained XhoI and SalI restriction sites flanking their 5′ and 3′ termini, respectively. The PCR product was subcloned into the polylinker (XhoI and SalI digested) of pBluescript KS II+ (Stratagene) (pKS/Fas), sequenced and recloned into MF3E [23] (or a derivative) at the XhoI or SalI sites. To make Fas-cg, the fragment amplified using primers 11611 and 12295, 5′-ggc ttt gtt cga aag aat ggt Aac aat gaa gcc aaa ata g-3′ (mutation capitalized), was digested with BstBI and SalI and subcloned into BstBI-SalI-digested pKS/Fas.
Transfections
Jurkat-TAg cells were transiently transfected in complete media as described previously [23] . Briefly, 10 7 Jurkat-TAg cells were electroporated with 4 g of the various constructs using a Gene Pulser (BioRad) at 250 V and 960 F. After 5 min, cells (0.4 ml in a 0.4 cm cuvette) were diluted into 10 ml complete media. D10.11 cells were transfected by a similar protocol except that after 24 h we added 2 mg ml -1 G418 to 100 l aliquots of transfected cells in complete media containing IL-2. G418-resistant colonies were thereafter cloned by standard techniques.
DNA laddering assay
We treated 3 × 10 6 D10.11 cells (or subclones) for various times with 500 nM FK1012. After the incubations genomic DNA was prepared by standard protocols. DNA pellets were resuspended in 20 l TE and separated on 1.8 % agarose gels containing 0.5 g ml -1 ethidium bromide.
FACS analysis and sorting
For thymocyte CD4 CD8 staining, approximately 2 × 10 6 thymocytes were washed with staining media (PBS, 2 % calf serum) and resuspended in 30 l staining media containing 1:100 dilutions of CD4-FITC and CD8-PE (CALTAG Labs.). Cells were incubated in the dark for 20-30 min on ice and washed twice with staining media. Cells were resuspended in 0.4 ml of staining media containing 1 g ml -1 propidium iodide and analyzed by FACS (FACScan-Becton Dickerson).
In order to enrich for transiently transfected Jurkat-TAg cells from the bulk electropulsed population, 1 g of pCA28⌬1 [40] , which expressed human CD8 without its cytoplasmic domain, was cotransfected into Jurkat-TAg cells along with one of several Fas/FKBP constructs. After 24 h, transfected cells were stained with mouse anti-human CD8-PE in 100 l, diluted in buffer containing propidium iodide, and isolated by FACS (Facstar). The brightest 50 000 cells (~2-2.5 % total) were isolated, washed and further treated as described.
Microscopy
Phase contrast microscopy was performed using a Zeiss Axiophot microscope and Ektachrome 400 film. For fluorescence microscopy, cells were prepared and stained as described previously [28] and imaged by confocal microscopy (BioRad). Briefly, transfected cells were settled for 10 min onto coverslips coated with 1 mg ml -1 poly-Llysine (Sigma P-2636) solution. Coverslips were rinsed in PBS and treated for 10 min with 4 % paraformaldehyde in PBS at room temperature, washed twice with PBS, permeabilized with methanol for 2 min at room temperature, and rinsed four times with PBS (or until all methanol was removed). Permeabilized cells were incubated with primary antibody 12CA5 (~1 g ml -1 ) in PBS containing 3 % BSA for 45 min at room temperature, washed three times in PBS, incubated with FITClabeled secondary antibody (1:2000 of goat anti-mouse IgG (H + L), Pharmingen) for 30 min at room temperature, and rinsed three times in PBS. Lastly, coverslips/cells were mounted on a drop of 75 % glycerol, containing 25 mM Tris-HCl (pH 8) and 0.1 % p-phenylenediamine.
Transgenic mice
The transgenic construct, Lck p -M/FKBP12/Fas/E was isolated as a NotI fragment from the expression vector plck-HGH, and purified by CsCl centrifugation. Mice were made by standard procedures. Transgenic mice were screened by the PCR from tail DNA using primers #17851/Fas1(5′): 5′-cat gca gaa agc aca gaa agg aa-3′ and #17852/hgh-3′: 5′-ggc gga gac tag cgt tgt caa-3′ giving an 880 bp band. Transgene positive mice were assayed for protein expression by western blotting of thymocyte extracts using 12CA5 as previously described [23] .
FK1012 was administered as a single intravenous injection. Briefly, 40 l of 10 g ml -1 FK1012 (in a solution containing a 1:1 ratio of dimethylacetamide and 90 % PEG400/10 % TWEEN 80) was injected under anesthesia (Metofane) into the retro-orbital sinus of mice aged 4-5 weeks. Approximately 16 h later, mice were euthanized by CO 2 and analyzed.
